Wednesday, January 4, 2012

Molecular Therapy - Table of Contents alert Volume 20 Issue 1

TABLE OF CONTENTS

Volume 20, Issue 1 (January 2012)

In this issue
Editorial
In This Issue
Research Highlights
Letters to the Editor
Commentaries
Review
Original Articles
Corrigendum

Also new
AOP

Sign up for e-alerts Sign up for e-alerts
Recommend to your library
Web feed
Subscribe
Advertisement
Molecular Therapy is accepting submissions!

Featuring author benefits like ZERO submission fees, Advanced Online Publication (AOP) at http://www.nature.com/mt/journal/vaop/ncurrent/index.html, and inclusion in abstracting and indexing services like ISI, MEDLINE and EMBASE. Molecular Therapy is the only journal ranked within the top 20th percentile in biotechnology, genetics and medicine.

To learn more about publishing in Molecular Therapy visit http://www.moleculartherapy.org.
 

Editorial

Top

Mathematical Modeling in Immunotherapy of Cancer: Personalizing Clinical Trials

Zvia Agur and Stanimir Vuk-Pavlović

Mol Ther 2012 20: 1-2; 10.1038/mt.2011.272

Full Text

In This Issue

Top

In This Issue

Mol Ther 2012 20: 4; 10.1038/mt.2011.278

Full Text

Research Highlights

Top

Research Highlights

Mol Ther 2012 20: 5; 10.1038/mt.2011.279

Full Text

Letters to the Editor

Top

Is Serum IL-17A a Useful Systemic Biomarker in Patients With Langerhans Cell Histiocytosis?

Polyzois Makras, Stergios A Polyzos, Athanasios D Anastasilakis, Evangelos Terpos, Athanasios Papatheodorou and Gregory A Kaltsas

Mol Ther 2012 20: 6-7; 10.1038/mt.2011.239

Full Text

Commentaries

Top

Antisense Oligonucleotides Shed New Light on the Pathogenesis and Treatment of Spinal Muscular Atrophy

Jiing-Kuan Yee and Ren-Jang Lin

Mol Ther 2012 20: 8-10; 10.1038/mt.2011.275

Full Text

Multifunctional Theranostic Nanoparticles for Brain Tumors

Yuhua Wang and Leaf Huang

Mol Ther 2012 20: 10-11; 10.1038/mt.2011.274

Full Text

Live and Let Die: A New Suicide Gene Therapy Moves to the Clinic

Richard A Morgan

Mol Ther 2012 20: 11-13; advance online publication, January 1, 2011; 10.1038/mt.2011.273

Full Text

Review

Top

Mesenchymal Stem/Stromal Cells (MSCs): Role as Guardians of Inflammation

Darwin J Prockop and Joo Youn Oh

Mol Ther 2012 20: 14-20; advance online publication, October 18, 2011; 10.1038/mt.2011.211

Abstract | Full Text

Original Articles

Top

Spinal Delivery of AAV Vector Restores Enzyme Activity and Increases Ventilation in Pompe Mice

Kai Qiu, Darin J Falk, Paul J Reier, Barry J Byrne and David D Fuller

Mol Ther 2012 20: 21-27; advance online publication, October 18, 2011; 10.1038/mt.2011.214

Abstract | Full Text

ACE2 and Ang-(1-7) Confer Protection Against Development of Diabetic Retinopathy

Amrisha Verma, Zhiying Shan, Bo Lei, Lihui Yuan, Xuan Liu, Takahiko Nakagawa, Maria B Grant, Alfred S Lewin, William W Hauswirth, Mohan K Raizada and Qiuhong Li

Mol Ther 2012 20: 28-36; advance online publication, July 26, 2011; 10.1038/mt.2011.155

Abstract | Full Text

Bevacizumab With Angiostatin-armed oHSV Increases Antiangiogenesis and Decreases Bevacizumab-induced Invasion in U87 Glioma

Wei Zhang, Giulia Fulci, Jason S Buhrman, Anat O Stemmer-Rachamimov, John W Chen, Gregory R Wojtkiewicz, Ralph Weissleder, Samuel D Rabkin and Robert L Martuza

Mol Ther 2012 20: 37-45; advance online publication, September 13, 2011; 10.1038/mt.2011.187

Abstract | Full Text

2A Peptide-based, Lentivirus-mediated Anti-death Receptor 5 Chimeric Antibody Expression Prevents Tumor Growth in Nude Mice

Meng Li, Yaomin Wu, Yuhe Qiu, Zhenyu Yao, Shilian Liu, Yanxin Liu, Juan Shi and Dexian Zheng

Mol Ther 2012 20: 46-53; advance online publication, September 20, 2011; 10.1038/mt.2011.197

Abstract | Full Text

Adenovirus i-Leader Truncation Bioselected Against Cancer-associated Fibroblasts to Overcome Tumor Stromal Barriers

Cristina Puig-Saus, Alena Gros, Ramon Alemany and Manel Cascalló

Mol Ther 2012 20: 54-62; advance online publication, August 23, 2011; 10.1038/mt.2011.159

Abstract | Full Text

Optimization of hCFTR Lung Expression in Mice Using DNA Nanoparticles

Linas Padegimas, Tomasz H Kowalczyk, Sam Adams, Chris R Gedeon, Sharon M Oette, Karla Dines, Susannah L Hyatt, Ozge Sesenoglu-Laird, Olena Tyr, Robert C Moen and Mark J Cooper

Mol Ther 2012 20: 63-72; advance online publication, September 27, 2011; 10.1038/mt.2011.196

Abstract | Full Text

Neutralizing Antibodies Against AAV Serotypes 1, 2, 6, and 9 in Sera of Commonly Used Animal Models

Kleopatra Rapti, Vedell Louis-Jeune, Erik Kohlbrenner, Kiyotake Ishikawa, Dennis Ladage, Sergei Zolotukhin, Roger J Hajjar and Thomas Weber

Mol Ther 2012 20: 73-83; advance online publication, September 13, 2011; 10.1038/mt.2011.177

Abstract | Full Text

Evaluation of Residual Promoter Activity in γ-Retroviral Self-inactivating (SIN) Vectors

Wenqin Xu, Jill L Russ and Maribeth V Eiden

Mol Ther 2012 20: 84-90; advance online publication, October 18, 2011; 10.1038/mt.2011.204

Abstract | Full Text

Delivery of siRNA to the Mouse Lung via a Functionalized Lipopolyamine

Kevin J Polach, Majed Matar, Jennifer Rice, Gregory Slobodkin, Jeff Sparks, Richard Congo, Angela Rea-Ramsey, Diane McClure, Elaine Brunhoeber, Monika Krampert, Andrea Schuster, Kerstin Jahn-Hofmann, Matthias John, Hans-Peter Vornlocher, Jason G Fewell, Khursheed Anwer and Anke Geick

Mol Ther 2012 20: 91-100; advance online publication, October 11, 2011; 10.1038/mt.2011.210

Abstract | Full Text

Short-interfering RNAs Induce Retinal Degeneration via TLR3 and IRF3

Mark E Kleinman, Hiroki Kaneko, Won Gil Cho, Sami Dridi, Benjamin J Fowler, Alexander D Blandford, Romulo JC Albuquerque, Yoshio Hirano, Hiroko Terasaki, Mineo Kondo, Takashi Fujita, Balamurali K Ambati, Valeria Tarallo, Bradley D Gelfand, Sasha Bogdanovich, Judit Z Baffi and Jayakrishna Ambati

Mol Ther 2012 20: 101-108; advance online publication, October 11, 2011; 10.1038/mt.2011.212

Abstract | Full Text

Targeted Gene Modification of Hematopoietic Progenitor Cells in Mice Following Systemic Administration of a PNA-peptide Conjugate

Faye A Rogers, Sharon S Lin, Denise C Hegan, Diane S Krause and Peter M Glazer

Mol Ther 2012 20: 109-118; advance online publication, August 9, 2011; 10.1038/mt.2011.163

Abstract | Full Text

Bifunctional RNAs Targeting the Intronic Splicing Silencer N1 Increase SMN Levels and Reduce Disease Severity in an Animal Model of Spinal Muscular Atrophy

Erkan Y Osman, Pei-Fen Yen and Christian L Lorson

Mol Ther 2012 20: 119-126; advance online publication, October 25, 2011; 10.1038/mt.2011.232

Abstract | Full Text

Efficient Generation of Functional Hepatocytes From Human Embryonic Stem Cells and Induced Pluripotent Stem Cells by HNF4α Transduction

Kazuo Takayama, Mitsuru Inamura, Kenji Kawabata, Kazufumi Katayama, Maiko Higuchi, Katsuhisa Tashiro, Aki Nonaka, Fuminori Sakurai, Takao Hayakawa, Miho Kusuda Furue and Hiroyuki Mizuguchi

Mol Ther 2012 20: 127-137; advance online publication, November 8, 2011; 10.1038/mt.2011.234

Abstract | Full Text

Human Skeletal Muscle Cells With a Slow Adhesion Rate After Isolation and an Enhanced Stress Resistance Improve Function of Ischemic Hearts

Masaho Okada, Thomas R Payne, Lauren Drowley, Ron J Jankowski, Nobuo Momoi, Sarah Beckman, William CW Chen, Bradley B Keller, Kimimasa Tobita and Johnny Huard

Mol Ther 2012 20: 138-145; advance online publication, November 8, 2011; 10.1038/mt.2011.229

Abstract | Full Text

Slowing Down Differentiation of Engrafted Human Myoblasts Into Immunodeficient Mice Correlates With Increased Proliferation and Migration

Ingo Riederer, Elisa Negroni, Maximilien Bencze, Annie Wolff, Ahmed Aamiri, James P Di Santo, Suse D. Silva-Barbosa, Gillian Butler-Browne, Wilson Savino and Vincent Mouly

Mol Ther 2012 20: 146-154; advance online publication, September 20, 2011; 10.1038/mt.2011.193

Abstract | Full Text

N-cadherin Determines Individual Variations in the Therapeutic Efficacy of Human Umbilical Cord Blood-derived Mesenchymal Stem Cells in a Rat Model of Myocardial Infarction

Eun Ju Lee, Eue-Keun Choi, Soo Kyoung Kang, Gi-Hwan Kim, Ju Young Park, Hyun-Jae Kang, Sae-Won Lee, Keum-Hyun Kim, Jin Sook Kwon, Ki Hong Lee, Youngkeun Ahn, Ho-Jae Lee, Hyun-Jai Cho, Soo Jin Choi, Won Il Oh, Young-Bae Park and Hyo-Soo Kim

Mol Ther 2012 20: 155-167; advance online publication, November 8, 2011; 10.1038/mt.2011.202

Abstract | Full Text

Long-term Engraftment of Multipotent Mesenchymal Stromal Cells That Differentiate to Form Myogenic Cells in Dogs With Duchenne Muscular Dystrophy

Yuko Nitahara-Kasahara, Hiromi Hayashita-Kinoh, Sachiko Ohshima-Hosoyama, Hironori Okada, Michiko Wada-Maeda, Akinori Nakamura, Takashi Okada and Shin'ichi Takeda

Mol Ther 2012 20: 168-177; advance online publication, September 20, 2011; 10.1038/mt.2011.181

Abstract | Full Text

Aire Controls Mesenchymal Stem Cell-mediated Suppression in Chronic Colitis

Biju Parekkadan, Anne L Fletcher, Matthew Li, Melissa Y Tjota, Angelique Bellemare-Pelletier, Jack M Milwid, Je-Wook Lee, Martin L Yarmush and Shannon J Turley

Mol Ther 2012 20: 178-186; advance online publication, September 27, 2011; 10.1038/mt.2011.192

Abstract | Full Text

Human MSC Suppression Correlates With Cytokine Induction of Indoleamine 2,3-Dioxygenase and Bystander M2 Macrophage Differentiation

Moïra François, Raphaëlle Romieu-Mourez, Mengyang Li and Jacques Galipeau

Mol Ther 2012 20: 187-195; advance online publication, September 20, 2011; 10.1038/mt.2011.189

Abstract | Full Text

Distinct Strategies Are Required to Suppress Antigen-specific Responses to Genetically Modified Keratinocytes and Fibroblasts

Soosan Ghazizadeh, Li T Huang and Weibing Zhang

Mol Ther 2012 20: 196-203; advance online publication, October 11, 2011; 10.1038/mt.2011.205

Abstract | Full Text

Normal Collagen and Bone Production by Gene-targeted Human Osteogenesis Imperfecta iPSCs

David R Deyle, Iram F Khan, Gaoying Ren, Pei-Rong Wang, Jordan Kho, Ulrike Schwarze and David W Russell

Mol Ther 2012 20: 204-213; advance online publication, October 25, 2011; 10.1038/mt.2011.209

Abstract | Full Text

Safety and Tolerability of the Easy Vax™ Clinical Epidermal Electroporation System in Healthy Adults

Samer S El-Kamary, Melissa Billington, Stephen Deitz, Elaina Colby, Howard Rhinehart, Yukun Wu, William Blackwelder, Robert Edelman, Albert Lee and Alan King

Mol Ther 2012 20: 214-220; advance online publication, November 8, 2011; 10.1038/mt.2011.235

Abstract | Full Text

Verapamil Results in Increased Blood Levels of Oncolytic Adenovirus in Treatment of Patients With Advanced Cancer

Anniina Koski, Mari Raki, Petri Nokisalmi, Ilkka Liikanen, Lotta Kangasniemi, Timo Joensuu, Anna Kanerva, Sari Pesonen, Ramon Alemany and Akseli Hemminki

Mol Ther 2012 20: 221-229; advance online publication, November 1, 2011; 10.1038/mt.2011.230

Abstract | Full Text

Hematopoietic Stem Cell Mobilization for Gene Therapy of Adult Patients With Severe β-Thalassemia: Results of Clinical Trials Using G-CSF or Plerixafor in Splenectomized and Nonsplenectomized Subjects

Evangelia Yannaki, Thalia Papayannopoulou, Erica Jonlin, Fani Zervou, Garyfalia Karponi, Angeliki Xagorari, Pamela Becker, Nikoleta Psatha, Ioannis Batsis, Panayotis Kaloyannidis, Varvara Tahynopoulou, Varnavas Constantinou, Asimina Bouinta, Konstantia Kotta, Aglaia Athanassiadou, Achilles Anagnostopoulos, Athanasios Fassas and George Stamatoyannopoulos

Mol Ther 2012 20: 230-238; advance online publication, September 27, 2011; 10.1038/mt.2011.195

Abstract | Full Text

Corrigendum

Top

Corrigendum: Treatment of Brain Inflammatory Diseases by Delivering Exosome Encapsulated Anti-Inflammatory Drugs From the Nasal Region to the Brain

Mol Ther 2012 20: 239; 10.1038/mt.2011.222

Full Text

Dedicated to the treatment of genetic and acquired diseases? So are we.

Molecular Therapy publishes top peer-reviewed original research and reviews focusing on molecular therapies to treat these diseases. Highly regarded, it is the only journal ranked within the top 13th percentile in Genetics, Medicine and Biotechnology.

Visit Molecular Therapy online at http://www.moleculartherapy.org and read a FREE sample issue today.
 

Please note that you need to be a subscriber or site-license holder to enjoy full-text access to Molecular Therapy. In order to do so, please purchase a subscription.

You have been sent this Table of Contents Alert because you have opted in to receive it. You can change or discontinue your e-mail alerts at any time, by modifying your preferences on your nature.com account at: www.nature.com/nams/svc/myaccount (You will need to log in to be recognised as a nature.com registrant).

For further technical assistance, please contact our registration department.

For print subscription enquiries, please contact our subscription department.

For other enquiries, please contact our customer feedback department.

Nature Publishing Group | 75 Varick Street, 9th Floor | New York | NY 10013-1917 | USA

Nature Publishing Group's worldwide offices:
London - Paris - Munich - New Delhi - Tokyo - Melbourne
San Diego - San Francisco - Washington - New York - Boston

Macmillan Publishers Limited is a company incorporated in England and Wales under company number 785998 and whose registered office is located at Brunel Road, Houndmills, Basingstoke, Hampshire RG21 6XS.

© 2011 Nature Publishing Group, a division of Macmillan Publishers Limited. All Rights Reserved.

nature publishing group
 

No comments: